SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-050282
Filing Date
2017-08-08
Accepted
2017-08-08 16:31:38
Documents
49
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-13327_110q.htm 10-Q 1007532
2 EX-31.1 a17-13327_1ex31d1.htm EX-31.1 13404
3 EX-31.2 a17-13327_1ex31d2.htm EX-31.2 12945
4 EX-32.1 a17-13327_1ex32d1.htm EX-32.1 7143
5 EX-32.2 a17-13327_1ex32d2.htm EX-32.2 7124
  Complete submission text file 0001104659-17-050282.txt   4415912

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT loxo-20170630.xml EX-101.INS 1057543
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT loxo-20170630.xsd EX-101.SCH 32008
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT loxo-20170630_cal.xml EX-101.CAL 28151
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT loxo-20170630_def.xml EX-101.DEF 115748
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT loxo-20170630_lab.xml EX-101.LAB 314870
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT loxo-20170630_pre.xml EX-101.PRE 208273
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36562 | Film No.: 171015246
SIC: 2834 Pharmaceutical Preparations